Linden Advisors’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.84K Hold
550,119
﹤0.01% 559
2025
Q4
$8.97K Hold
550,119
﹤0.01% 463
2025
Q3
$21.5K Hold
550,119
﹤0.01% 391
2025
Q2
$27.5K Hold
550,119
﹤0.01% 352
2025
Q1
$20.7K Hold
550,119
﹤0.01% 284
2024
Q4
$11.9K Hold
550,119
﹤0.01% 245
2024
Q3
$4.95K Hold
550,119
﹤0.01% 265
2024
Q2
$9.68K Hold
550,119
﹤0.01% 263
2024
Q1
$25K Hold
550,119
﹤0.01% 259
2023
Q4
$18.2K Hold
550,119
﹤0.01% 262
2023
Q3
$7.54K Hold
550,119
﹤0.01% 347
2023
Q2
$29.1K Hold
550,119
﹤0.01% 300
2023
Q1
$32.7K Hold
550,119
﹤0.01% 349
2022
Q4
$53.9K Hold
550,119
﹤0.01% 407
2022
Q3
$183K Hold
550,119
﹤0.01% 468
2022
Q2
$301K Sell
550,119
-236,219
-30% -$233K ﹤0.01% 484
2022
Q1
$1.09M Sell
786,338
-1,547,264
-66% -$1.26M 0.01% 479
2021
Q4
$1.87M Sell
2,333,602
-10,000
-0.4% -$10.1K 0.01% 449
2021
Q3
$2.68M Sell
2,343,602
-468,627
-17% -$627K 0.02% 380
2021
Q2
$3.92M Hold
2,812,229
0.02% 377
2021
Q1
$3.08M Sell
2,812,229
-78,769
-3% -$123K 0.02% 390
2020
Q4
$7.95M Hold
2,890,998
0.06% 183
2020
Q3
$4.55M Buy
2,890,998
+490,149
+20% +$739K 0.05% 165
2020
Q2
$2.59M Buy
2,400,849
+1,042,850
+77% +$688K 0.04% 144
2020
Q1
$652K Buy
1,357,999
+1,850
+0.1% +$1.58K 0.01% 171
2019
Q4
$1.06M Buy
1,356,149
+100,000
+8% +$70.7K 0.01% 173
2019
Q3
$735K Buy
+1,256,149
New +$719K 0.01% 165

Other funds holding CELUW

Linden Advisors's CELUW Position: Q1 2026 in Review

Linden Advisors held its Celularity Inc (CELUW) position steady in Q1 2026 at 550,119 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Linden Advisors first reported a position in CELUW in Q3 2019 and has held it in 27 quarters since. The position peaked at $7.95M in Q4 2020. 14 funds tracked by Wall St. Rank hold CELUW as of Q1 2026.

  • Linden Advisors held 550,119 shares of Celularity Inc worth $4.84K as of Q1 2026.
  • Linden Advisors left its Celularity Inc share count unchanged in Q1 2026.
  • Celularity Inc made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #559 holding.
  • Linden Advisors first reported a position in Celularity Inc in Q3 2019 and has held it in 27 quarters since.
  • Linden Advisors's Celularity Inc position peaked at $7.95M in Q4 2020.
  • 14 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.